Skip to content
10-Q

Quarterly Report

Chinook Therapeutics, Inc.

0000950170-23-039041

← back to feed
Filed
Aug 7, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 71.8M sh
Shares Diluted Q2 2023 · Jun 30, 2023 71.59M sh
Shares Diluted Q2 2023 · Jun 30, 2023 71.15M sh
Shares Diluted Q2 2023 · Jun 30, 2022 61.98M sh
Shares Diluted Q2 2023 · Jun 30, 2022 60.18M sh
Capex Q2 2023 · Jun 30, 2023 $1.55M
Capex Q2 2023 · Jun 30, 2022 $601K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$111.86M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$55.34M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $127.15M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $115.44M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $145.93M
Stockholders Equity Q2 2023 · Jun 30, 2023 $357.04M
Stockholders Equity Q2 2023 · Mar 31, 2023 $412.39M
Stockholders Equity Q2 2023 · Dec 31, 2022 $441.94M
Stockholders Equity Q2 2023 · Jun 30, 2022 $507.13M
Stockholders Equity Q2 2023 · Mar 31, 2022 $426.8M
Stockholders Equity Q2 2023 · Dec 31, 2021 $453.64M
Current Liabilities Q2 2023 · Jun 30, 2023 $52.47M
Current Liabilities Q2 2023 · Dec 31, 2022 $50.84M
Total Liabilities Q2 2023 · Jun 30, 2023 $131.77M
Total Liabilities Q2 2023 · Dec 31, 2022 $132.14M
Current Assets Q2 2023 · Jun 30, 2023 $305.42M
Current Assets Q2 2023 · Dec 31, 2022 $385.59M
Total Assets Q2 2023 · Jun 30, 2023 $488.81M
Total Assets Q2 2023 · Dec 31, 2022 $574.08M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.94
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.79
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$0.61
Eps Diluted Q2 2023 · Jun 30, 2022 −$1.15
Eps Basic Q2 2023 · Jun 30, 2023 −$0.94
Eps Basic Q2 2023 · Jun 30, 2023 −$1.79
Eps Basic Q2 2023 · Jun 30, 2022 −$0.61
Eps Basic Q2 2023 · Jun 30, 2022 −$1.15
Sga Expense Q2 2023 · Jun 30, 2023 $13.06M
Sga Expense Q2 2023 · Jun 30, 2023 $24.47M
Sga Expense Q2 2023 · Jun 30, 2022 $8.64M
Sga Expense Q2 2023 · Jun 30, 2022 $16.5M
Rd Expense Q2 2023 · Jun 30, 2023 $57.9M
Rd Expense Q2 2023 · Jun 30, 2023 $108.78M
Rd Expense Q2 2023 · Jun 30, 2022 $30.02M
Rd Expense Q2 2023 · Jun 30, 2022 $56.28M
Net Income Q2 2023 · Jun 30, 2023 −$66.94M
Net Income Q2 2023 · Jun 30, 2023 −$127.12M
Net Income Q2 2023 · Mar 31, 2023 −$60.18M
Net Income Q2 2023 · Jun 30, 2022 −$37.65M
Net Income Q2 2023 · Jun 30, 2022 −$69.33M
Net Income Q2 2023 · Mar 31, 2022 −$31.68M
Operating Income Q2 2023 · Jun 30, 2023 −$72.63M
Operating Income Q2 2023 · Jun 30, 2023 −$134.04M
Operating Income Q2 2023 · Jun 30, 2022 −$36.69M
Operating Income Q2 2023 · Jun 30, 2022 −$67.5M
Revenue Q2 2023 · Jun 30, 2023 $1.01M
Revenue Q2 2023 · Jun 30, 2023 $2.84M
Revenue Q2 2023 · Jun 30, 2022 $418K
Revenue Q2 2023 · Jun 30, 2022 $3.12M